XML 55 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Jun. 30, 2012
Jun. 30, 2011
OPERATING ACTIVITIES:    
Net income $ 423,930 $ 312,766
Adjustment for loss from discontinued operations 73 388
Income from continuing operations 424,003 313,154
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 272,404 228,450
Provision for bad debt 2 3
Stock-based compensation 13,300 9,114
Other 134 3
Gain on sale of investment securities   (913)
Income from asset sales (14,365) (10,262)
Deferred income tax expense 144,729 155,630
Change in assets and liabilities-    
Accounts receivable (143,809) 13,442
Inventories (16,012) (6,204)
Prepaid expenses and other (41,287) (7,040)
Accounts payable (13,899) (14,379)
Accrued liabilities (7,768) 15,247
Deferred income taxes (326) 209
Other noncurrent liabilities (4,055) 377
Net cash provided by operating activities from continuing operations 613,051 696,831
Net cash used in operating activities from discontinued operations (73) (388)
Net cash provided by operating activities 612,978 696,443
INVESTING ACTIVITIES:    
Capital expenditures (774,243) (493,776)
Proceeds from sale of investment securities   3,932
Proceeds from asset sales 31,838 21,738
Acquisition of TerraVici Drilling Solutions   (4,000)
Net cash used in investing activities (742,405) (472,106)
FINANCING ACTIVITIES:    
Proceeds from line of credit   10,000
Payments on line of credit   (20,000)
Repurchase of common stock (71,404)  
Increase in bank overdraft 3,955 4,844
Dividends paid (22,620) (19,222)
Exercise of stock options 2,374 13,734
Tax withholdings related to net share settlements of restricted stock (1,514)  
Excess tax benefit from stock-based compensation 3,256 11,352
Net cash used in financing activities (85,953) 708
Net increase (decrease) in cash and cash equivalents (215,380) 225,045
Cash and cash equivalents, beginning of period 364,246 63,020
Cash and cash equivalents, end of period $ 148,866 $ 288,065